Site #3

New York, New York 10065

1 studies enrolling now · 2 studies all time

What they study most

Excessive Daytime Sleepiness, Multiple Myeloma

Studies at this site

• A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age — Recruiting now
• Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma — Completed